Sesen Bio, Inc.
SESN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$10,630 |
| % Growth | – | – | 100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$10,630 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $197 | $2,424 | $9,156 | $4,963 |
| G&A Expenses | $1,239 | $3,354 | $3,907 | $63 |
| SG&A Expenses | $1,239 | $3,354 | $3,907 | $63 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,436 | $5,778 | $13,063 | $5,026 |
| Operating Income | $43,814 | $0 | $0 | $67,595 |
| % Margin | – | – | – | -635.9% |
| Other Income/Exp. Net | $903 | $0 | $0 | $0 |
| Pre-Tax Income | $44,717 | -$9,774 | -$9,266 | $5,641 |
| Tax Expense | $0 | $0 | $0 | $197 |
| Net Income | $44,717 | -$9,774 | -$9,266 | $5,444 |
| % Margin | – | – | – | -51.2% |
| EPS | 1.07 | -0.23 | -0.22 | 1.49 |
| % Growth | 565.2% | -4.5% | -114.8% | – |
| EPS Diluted | 1.07 | -0.23 | -0.22 | 1.49 |
| Weighted Avg Shares Out | 41,788 | 41,788 | 41,544 | 41,456 |
| Weighted Avg Shares Out Dil | 41,940 | 41,788 | 41,544 | 41,456 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | -$641 |
| Depreciation & Amortization | $0 | $0 | $0 | -$787 |
| EBITDA | $44,717 | $0 | $0 | $4,213 |
| % Margin | – | – | – | -39.6% |